Magellan Health (MGLN) Tops Q3 EPS by 24c, Guides FY EPS Ahead of Views

Magellan Health (NASDAQ: MGLN) reported Q3 EPS of $1.64, $0.24 better than the analyst estimate of $1.40. Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.49 billion.

GUIDANCE:

Magellan Health sees FY2017 EPS of $5.45-$5.86, versus the consensus of $5.13. Magellan Health sees FY2017 revenue of $5.75-5.85 billion, versus the consensus of $5.8 billion.

For earnings history and earnings-related data on Magellan Health (MGLN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c